Approved HIV Drugs
CROI 2008: Abacavir/3TC (Epzicom) Matches Tenofovir/Emtricitabine (Truvada) for Treatment-naive Patients: HEAT Study
- Details
- Category: HIV Treatment
- Published on Tuesday, 05 February 2008 12:58
- Written by HIVandHepatitis.com
While there is always much interest in new antiretroviral drug classes, research continues as well on the earliest type of anti-HIV therapy, nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). At the 15th Conference on Retroviruses and Opportunistic Infections (CROI 2008) this week in Boston, researchers presented data from the HEAT (Head-to-head Epzicom And Truvada) trial, a direct comparison of 2 double-NRTI backbones.
Atazanavir (Reyataz) Label Changes Cover Drug Interactions, Kidney Impairment
- Details
- Category: Approved HIV Drugs
- Published on Friday, 18 January 2008 13:09
- Written by FDA
The U.S. Food and Drug Administration this week announced revisions to the package insert for the protease inhibitor atazanavir (Reyataz), reflecting new information about administration with food, interaction with several drugs, and use by patients with impaired kidney function.